{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:52:29Z","timestamp":1785761549431,"version":"3.56.0"},"reference-count":163,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Laboratory Major Special Project","award":["25ZXZSSS00350"],"award-info":[{"award-number":["25ZXZSSS00350"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Fungi","JoF"],"abstract":"<jats:p>Antifungal resistance in filamentous fungi has emerged as a major threat to global public health, posing a serious challenge particularly to immunocompromised populations. This review provides a systematic overview of the molecular mechanisms, diagnostic approaches, and clinical therapeutic strategies for antifungal resistance in filamentous fungi, with a focus on Aspergillus fumigatus, Fusarium spp., Mucorales, and Scedosporium spp.\/Lomentospora prolificans. Resistance mechanisms can be broadly categorized as intrinsic resistance and acquired resistance. Intrinsic resistance arises from species-specific genetic traits, such as structural differences in target sites, constitutive overexpression of efflux pumps, and metabolic pathway redundancy. Acquired resistance develops under drug pressure through target gene mutations (e.g., hotspot mutations and promoter tandem repeats in CYP51A), efflux pump overexpression, biofilm formation, and epigenetic regulation. For diagnosis, conventional culture and antifungal susceptibility testing remain the gold standard; however, molecular techniques\u2014including MALDI-TOF MS, targeted resistance gene PCR, and metagenomics\u2014are substantially improving detection efficiency. Therapeutic strategies should be stratified based on antifungal susceptibility testing results and species identification. Precision dosing guided by therapeutic drug monitoring, combination therapy, and the introduction of novel agents (including isavuconazole, rezafungin, fosmanogepix, and olorofim) are progressively improving clinical outcomes. Looking ahead, global surveillance and multisectoral collaboration are essential to deepen our understanding of resistance evolution, accelerate the clinical translation of novel diagnostic and therapeutic tools, and curb the global spread of resistance.<\/jats:p>","DOI":"10.3390\/jof12080565","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:50:21Z","timestamp":1785757821000},"page":"565","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Mechanisms, Diagnosis, and Therapeutic Strategies of Antifungal Resistance in Filamentous Fungi"],"prefix":"10.3390","volume":"12","author":[{"given":"Yajing","family":"Yin","sequence":"first","affiliation":[{"name":"Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueru","family":"Zhao","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Universe Gene Technology (Tianjin) Co., Ltd., Tianjin 300134, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7246-7173","authenticated-orcid":false,"given":"Lei","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101215","DOI":"10.1016\/j.mam.2023.101215","article-title":"The changing epidemiology of fungal infections","volume":"94","author":"Steixner","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e0015922","DOI":"10.1128\/cmr.00159-22","article-title":"Invasive fusariosis","volume":"36","author":"Nucci","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e0000423","DOI":"10.1128\/cmr.00004-23","article-title":"Scedosporiosis and lomentosporiosis: Modern perspectives on these difficult-to-treat rare mold infections","volume":"37","author":"Neoh","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R., and Denning, D. (2017). Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00140-18","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Chamilos","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"220104","DOI":"10.1183\/16000617.0104-2022","article-title":"Non-Aspergillus mould lung infections","volume":"31","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Stemler, J., Tobben, C., Lass-Florl, C., Steinmann, J., Ackermann, K., Rath, P.M., Simon, M., Cornely, O.A., and Koehler, P. (2023). Diagnosis and treatment of invasive aspergillosis caused by non-fumigatus Aspergillus spp.. J. Fungi, 9.","DOI":"10.3390\/jof9040500"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Carvalho, A., Van De Veerdonk, F.L., Jenks, J.D., Koehler, P., Krause, R., Cornely, O.A., Perlin, D.S., Lass-Florl, C., and Hoenigl, M. (2020). COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment. J. Fungi, 6.","DOI":"10.3390\/jof6020091"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1038\/s41598-022-13443-3","article-title":"COVID-19 associated mucormycosis in Assiut University Hospitals: A multidisciplinary dilemma","volume":"12","author":"Abdelrady","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: A multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"Arendrup","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e0018822","DOI":"10.1128\/mmbr.00188-22","article-title":"Molecular mechanisms that govern infection and antifungal resistance in Mucorales","volume":"88","author":"Lax","year":"2024","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Al-Hatmi, A.M., Meis, J.F., and De Hoog, G.S. (2016). Fusarium: Molecular diversity and intrinsic drug resistance. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005464"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"myad128","DOI":"10.1093\/mmy\/myad128","article-title":"Fusarium species, Scedosporium species, and Lomentospora prolificans: A systematic review to inform the world health organization priority list of fungal pathogens","volume":"62","author":"Marinelli","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.FUNK-0002-2016","article-title":"Antifungal drugs: The current armamentarium and development of new agents","volume":"4","author":"Robbins","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"myaf089","DOI":"10.1093\/mmy\/myaf089","article-title":"Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Kawasaki","year":"2025","journal-title":"Med. Mycol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"dlaf219","DOI":"10.1093\/jacamr\/dlaf219","article-title":"Global epidemiology of azole resistance in Aspergillus fumigatus","volume":"8","author":"Fengler","year":"2026","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, D., Amburgey-Crovetti, K., Applebach, E., Steen, T.Y., and Calderone, R. (2025). The dual pathogen Fusarium: Diseases, incidence, azole resistance, and biofilms. J. Fungi, 11.","DOI":"10.3390\/jof11040294"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Burks, C., Darby, A., G\u00f3mez Londo\u00f1o, L., Momany, M., and Brewer, M.T. (2021). Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009711"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.medmal.2019.07.014","article-title":"Azole-resistant Aspergillus fumigatus: A global phenomenon originating in the environment?","volume":"50","author":"Jeanvoine","year":"2019","journal-title":"Med. Mal. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.scitotenv.2018.08.247","article-title":"Tebuconazole induces triazole-resistance in Aspergillus fumigatus in liquid medium and soil","volume":"648","author":"Cui","year":"2019","journal-title":"Sci. Total Environ."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/1040841X.2014.910749","article-title":"Bone and joint infections by Mucorales, Scedosporium, Fusarium and even rarer fungi","volume":"42","author":"Koehler","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/mmy\/myx119","article-title":"Aspergillus terreus: Novel lessons learned on amphotericin B resistance","volume":"56","author":"Posch","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mmcr.2016.04.005","article-title":"Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature","volume":"11","author":"Goldman","year":"2016","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Al-Hatmi, A.M.S., Curfs-Breuker, I., De Hoog, G.S., Meis, J.F., and Verweij, P.E. (2017). Antifungal susceptibility testing of Fusarium: A practical approach. J. Fungi, 3.","DOI":"10.3390\/jof3020019"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins\u2014Structure, mechanism of action and use in antifungal therapy","volume":"37","author":"Szymanski","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","article-title":"Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis","volume":"46","author":"Kirkpatrick","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1159746","article-title":"Outwitting multidrug resistance to antifungals","volume":"321","author":"Monk","year":"2008","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole Resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/JCM.40.7.2648-2650.2002","article-title":"Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998","volume":"40","author":"Verweij","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/47.3.333","article-title":"Acquired itraconazole resistance in Aspergillus fumigatus","volume":"47","author":"Dannaoui","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/44.4.553","article-title":"In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole","volume":"44","author":"Dannaoui","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/00365549709011864","article-title":"In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole","volume":"29","author":"Chryssanthou","year":"1997","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/AAC.00514-12","article-title":"Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rudramurthy, S.M., Paul, R.A., Chakrabarti, A., Mouton, J.W., and Meis, J.F. (2019). Invasive aspergillosis by Aspergillus flavus: Epidemiology, diagnosis, antifungal resistance, and management. J. Fungi, 5.","DOI":"10.3390\/jof5030055"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcrc.2019.02.005","article-title":"Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)","volume":"51","author":"Chakrabarti","year":"2019","journal-title":"J. Crit. Care"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3109\/13693786.2010.505206","article-title":"Invasive aspergillosis in developing countries","volume":"49","author":"Chakrabarti","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","article-title":"Aspergillus flavus: An emerging non-fumigatus Aspergillus species of significance","volume":"52","author":"Krishnan","year":"2009","journal-title":"Mycoses"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"ofy213","DOI":"10.1093\/ofid\/ofy213","article-title":"Emerging Aspergillus species almost exclusively associated with primary immunodeficiencies","volume":"5","author":"Seyedmousavi","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4614-4726-9_3","article-title":"Invasive fungal infections in patients with chronic granulomatous disease","volume":"764","author":"Henriet","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ijporl.2010.03.001","article-title":"Fungal infection of the ear: A common problem in the north eastern part of Haryana","volume":"74","author":"Aneja","year":"2010","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"O333","DOI":"10.1111\/1469-0691.12394","article-title":"Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital","volume":"20","author":"Vermeulen","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J. Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"776.e1","DOI":"10.1016\/j.cmi.2017.04.012","article-title":"A prospective international Aspergillus terreus survey: An EFISG, ISHAM and ECMM joint study","volume":"23","author":"Risslegger","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/21501203.2019.1574927","article-title":"Resistance mechanism and proteins in Aspergillus species against antifungal agents","volume":"10","author":"Shishodia","year":"2019","journal-title":"Mycology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semdp.2019.04.010","article-title":"Emerging and reemerging fungal infections","volume":"36","author":"Lockhart","year":"2019","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2666-5247(24)00042-9","article-title":"The WHO fungal priority pathogens list: A crucial reappraisal to review the prioritisation","volume":"5","author":"Casalini","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2017.06.017","article-title":"Current antifungal treatment of fusariosis","volume":"51","author":"Bonifaz","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Walther, G., Wagner, L., and Kurzai, O. (2019). Updates on the taxonomy of Mucorales with an emphasis on clinically important taxa. J. Fungi, 5.","DOI":"10.3390\/jof5040106"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Alqarihi, A., Kontoyiannis, D.P., and Ibrahim, A.S. (2023). Mucormycosis in 2023: An update on pathogenesis and management. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1254919"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Serris, A., Danion, F., and Lanternier, F. (2019). Disease entities in mucormycosis. J. Fungi, 5.","DOI":"10.3390\/jof5010023"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijantimicag.2017.08.010","article-title":"Antifungal resistance in mucorales","volume":"50","author":"Dannaoui","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid3006.231409","article-title":"Deciphering unexpected vascular locations of Scedosporium spp. and Lomentospora prolificans fungal infections, France","volume":"30","author":"Vignals","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2019.12.017","article-title":"Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope\u00ae and the literature","volume":"92","author":"Seidel","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: Prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Hosseini, P., Keniya, M.V., Sagatova, A.A., Toepfer, S., Muller, C., Tyndall, J.D.A., Klinger, A., Fleischer, E., and Monk, B.C. (2024). The molecular basis of the intrinsic and acquired resistance to azole antifungals in Aspergillus fumigatus. J. Fungi, 10.","DOI":"10.3390\/jof10120820"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1128\/AAC.05164-14","article-title":"Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains","volume":"59","author":"Blatzer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-0691.2012.03848.x","article-title":"In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus","volume":"19","author":"Blum","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1089\/ars.2014.6220","article-title":"Amphotericin B resistance in Aspergillus terreus is overpowered by coapplication of pro-oxidants","volume":"23","author":"Blatzer","year":"2015","journal-title":"Antioxid. Redox Signal"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e0392624","DOI":"10.1128\/mbio.03926-24","article-title":"Aspergillus terreus sectorization: A morphological phenomenon shedding light on amphotericin B resistance mechanism","volume":"16","author":"Eisele","year":"2025","journal-title":"mBio"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Becher, R., Weihmann, F., Deising, H.B., and Wirsel, S.G. (2011). Development of a novel multiplex DNA microarray for Fusarium graminearum and analysis of azole fungicide responses. BMC Genom., 12.","DOI":"10.1186\/1471-2164-12-52"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/AAC.05477-11","article-title":"The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis","volume":"56","author":"Liu","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"He, D., Feng, Z., Gao, S., Wei, Y., Han, S., and Wang, L. (2021). Contribution of NADPH-cytochrome P450 reductase to azole resistance in Fusarium oxysporum. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.709942"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Sun, H., Li, J., Ju, C., and Huang, J. (2022). The transcription factor FgAtrR regulates asexual and sexual development, virulence, and DON production and contributes to intrinsic resistance to azole fungicides in Fusarium graminearum. Biology, 11.","DOI":"10.3390\/biology11020326"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/AAC.00020-09","article-title":"Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae","volume":"53","author":"Katiyar","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"15898","DOI":"10.1038\/s41598-017-16123-9","article-title":"Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14alpha-demethylase","volume":"7","author":"Caramalho","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"26213","DOI":"10.1038\/srep26213","article-title":"Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14alpha-demethylase","volume":"6","author":"Sagatova","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e0031523","DOI":"10.1128\/spectrum.00315-23","article-title":"Characterization of the sterol 24-C-methyltransferase genes reveals a network of alternative sterol biosynthetic pathways in Mucor lusitanicus","volume":"11","author":"Bauer","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Nagy, G., Kiss, S., Varghese, R., Bauer, K., Szebenyi, C., Kocsube, S., Homa, M., Bodai, L., Zsindely, N., and Nagy, G. (2021). Characterization of three pleiotropic drug resistance transporter genes and their participation in the azole resistance of Mucor circinelloides. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.660347"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e0068622","DOI":"10.1128\/aac.00686-22","article-title":"Serine\/Threonine phosphatase calcineurin orchestrates the intrinsic resistance to micafungin in the human-pathogenic fungus Mucor circinelloides","volume":"67","author":"Garcia","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e02599-17","DOI":"10.1128\/AAC.02599-17","article-title":"Identification of 14-\u03b1-lanosterol demethylase (CYP51) in Scedosporium species","volume":"62","author":"Bernhardt","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e00318-20","DOI":"10.1128\/AAC.00318-20","article-title":"Antifungal susceptibility profiles and drug resistance mechanisms of clinical Lomentospora prolificans isolates","volume":"64","author":"Wu","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/dky517","article-title":"Emerging threat of triazole-resistant Aspergillus fumigatus","volume":"74","author":"Rybak","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., and Meis, J.F. (2015). Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00428"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.diagmicrobio.2012.06.030","article-title":"In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus","volume":"74","author":"Wu","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fgb.2015.06.001","article-title":"Genotype-phenotype complexity of the TR46\/Y121F\/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus","volume":"82","author":"Snelders","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Gsaller, F., Hortschansky, P., Furukawa, T., Carr, P.D., Rash, B., Capilla, J., M\u00fcller, C., Bracher, F., Bowyer, P., and Haas, H. (2016). Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT binding complex. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006106"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e02563-18","DOI":"10.1128\/mBio.02563-18","article-title":"AtrR is an essential determinant of azole resistance in Aspergillus fumigatus","volume":"10","author":"Paul","year":"2019","journal-title":"mBio"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1469-0691.2008.02099.x","article-title":"A 1-year Aspergillus terreus surveillance study at the university hospital of innsbruck: Molecular typing of environmental and clinical isolates","volume":"14","author":"Blum","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e01928-17","DOI":"10.1128\/AAC.01928-17","article-title":"Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India","volume":"62","author":"Sharma","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.00637-15","article-title":"A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus","volume":"59","author":"Paul","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Camps, S.M., Dutilh, B.E., Arendrup, M.C., Rijs, A.J., Snelders, E., Huynen, M.A., Verweij, P.E., and Melchers, W.J. (2012). Discovery of a hapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050034"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00437-19","DOI":"10.1128\/mBio.00437-19","article-title":"Mutations in hmg1, challenging the paradigm of clinical triazole resistance in Aspergillus fumigatus","volume":"10","author":"Rybak","year":"2019","journal-title":"mBio"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1087-1845(02)00016-6","article-title":"Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate","volume":"36","author":"Slaven","year":"2002","journal-title":"Fungal Genet. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/AAC.47.5.1719-1726.2003","article-title":"Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole","volume":"47","author":"Nascimento","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1534\/g3.117.300265","article-title":"The influence of genetic stability on Aspergillus fumigatus virulence and azole resistance","volume":"8","author":"Silva","year":"2018","journal-title":"G3"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e00416-19","DOI":"10.1128\/mSphere.00416-19","article-title":"The Aspergillus fumigatus mismatch repair MSH2 homolog is important for virulence and azole resistance","volume":"4","author":"Silva","year":"2019","journal-title":"mSphere"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1111\/1462-2920.15274","article-title":"Mechanisms of triazole resistance in Aspergillus fumigatus","volume":"22","author":"Nywening","year":"2020","journal-title":"Environ. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pestbp.2018.08.011","article-title":"Molecular and biological characteristics of laboratory metconazole-resistant mutants in Fusarium graminearum","volume":"152","author":"Duan","year":"2018","journal-title":"Pestic. Biochem. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/ps.4837","article-title":"The Y137H mutation in the cytochrome P450 FgCYP51B protein confers reduced sensitivity to tebuconazole in Fusarium graminearum","volume":"74","author":"Qian","year":"2018","journal-title":"Pest Manag. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1094\/PDIS-04-24-0880-RE","article-title":"Potential mechanisms of hexaconazole resistance in Fusarium graminearum","volume":"108","author":"Zhou","year":"2024","journal-title":"Plant Dis."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"James, J.E., Lamping, E., Santhanam, J., Milne, T.J., Abd Razak, M.F., Zakaria, L., and Cannon, R.D. (2020). A 23 bp cyp51A promoter deletion associated with voriconazole resistance in clinical and environmental isolates of Neocosmospora keratoplastica. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00272"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s41467-019-09145-6","article-title":"A phosphorylated transcription factor regulates sterol biosynthesis in Fusarium graminearum","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"137903","DOI":"10.1016\/j.ijbiomac.2024.137903","article-title":"The transcription factor FgCreA modulates ergosterol biosynthesis and sensitivity to DMI fungicides by regulating transcription of FgCyp51A and FgErg6A in Fusarium graminearum","volume":"284","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Ma, T., Li, Y., Lou, Y., Shi, J., Sun, K., Ma, Z., Yan, L., and Yin, Y. (2022). The drug H+ antiporter FgQdr2 is essential for multiple drug resistance, ion homeostasis, and pathogenicity in Fusarium graminearum. J. Fungi, 8.","DOI":"10.3390\/jof8101009"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Abou Ammar, G., Tryono, R., D\u00f6ll, K., Karlovsky, P., Deising, H.B., and Wirsel, S.G. (2013). Identification of ABC transporter genes of Fusarium graminearum with roles in azole tolerance and\/or virulence. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079042"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Qi, P.F., Zhang, Y.Z., Liu, C.H., Zhu, J., Chen, Q., Guo, Z.R., Wang, Y., Xu, B.J., Zheng, T., and Jiang, Y.F. (2018). Fusarium graminearum ATP-binding cassette transporter gene FgABCC9 is required for its transportation of salicylic acid, fungicide resistance, mycelial growth and pathogenicity towards wheat. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082351"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Hellin, P., King, R., Urban, M., Hammond-Kosack, K.E., and Legr\u00e8ve, A. (2018). The adaptation of Fusarium culmorum to DMI fungicides is mediated by major transcriptome modifications in response to azole fungicide, including the overexpression of a PDR transporter (FcABC1). Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01385"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/fmb-2019-0186","article-title":"Efflux pump inhibition controls growth and enhances antifungal susceptibility of Fusarium solani species complex","volume":"15","author":"Portela","year":"2020","journal-title":"Future Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"105311","DOI":"10.1016\/j.pestbp.2022.105311","article-title":"The calcium-calcineurin and high-osmolarity glycerol pathways co-regulate tebuconazole sensitivity and pathogenicity in Fusarium graminearum","volume":"190","author":"Wang","year":"2023","journal-title":"Pestic. Biochem. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Zhang, R., Wiederhold, N., Calderone, R., and Li, D. (2024). Biofilm formation in clinical isolates of Fusarium. J. Fungi, 10.","DOI":"10.3390\/jof10110766"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12275-019-8637-2","article-title":"Biofilm characterization of Fusarium solani keratitis isolate: Increased resistance to antifungals and UV light","volume":"57","year":"2019","journal-title":"J. Microbiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.micpath.2019.03.001","article-title":"Proteome analysis of biofilm produced by a Fusarium falciforme keratitis infectious agent","volume":"130","author":"Jones","year":"2019","journal-title":"Microb. Pathog."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jobm.201500759","article-title":"Fungal quorum sensing molecules: Role in fungal morphogenesis and pathogenicity","volume":"56","author":"Wongsuk","year":"2016","journal-title":"J. Basic Microbiol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Lee, S.C., Li, A., Calo, S., and Heitman, J. (2013). Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003625"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nature13575","article-title":"Antifungal drug resistance evoked via RNAi-dependent epimutations","volume":"513","author":"Calo","year":"2014","journal-title":"Nature"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e02949-19","DOI":"10.1128\/mBio.02949-19","article-title":"A novel resistance pathway for calcineurin inhibitors in the human-pathogenic Mucorales Mucor circinelloides","volume":"11","author":"Vellanki","year":"2020","journal-title":"mBio"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Son, Y.E., Perez-Arques, C., and Heitman, J. (2026). Epimutations driven by RNAi or heterochromatin evoke transient antimicrobial drug resistance in pathogenic Mucor fungi. PLoS Biol., 24.","DOI":"10.1371\/journal.pbio.3003598"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e02579-19","DOI":"10.1128\/mBio.02579-19","article-title":"Drug-resistant epimutants exhibit organ-specific stability and induction during murine infections caused by the human fungal pathogen Mucor circinelloides","volume":"10","author":"Chang","year":"2019","journal-title":"mBio"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Chang, Z., Billmyre, R.B., Lee, S.C., and Heitman, J. (2019). Broad antifungal resistance mediated by RNAi-dependent epimutation in the basal human fungal pathogen Mucor circinelloides. PLoS Genet., 15.","DOI":"10.1101\/526459"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Calo, S., Nicolas, F.E., Lee, S.C., Vila, A., Cervantes, M., Torres-Martinez, S., Ruiz-Vazquez, R.M., Cardenas, M.E., and Heitman, J. (2017). A non-canonical RNA degradation pathway suppresses RNAi-dependent epimutations in the human fungal pathogen Mucor circinelloides. PLoS Genet., 13.","DOI":"10.1371\/journal.pgen.1006686"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Pellon, A., Ramirez-Garcia, A., Buldain, I., Antoran, A., Rementeria, A., and Hernando, F.L. (2017). Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174885"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"myac036","DOI":"10.1093\/mmy\/myac036","article-title":"Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium\/Lomentospora genera","volume":"60","author":"Mello","year":"2022","journal-title":"Med. Mycol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/jac\/dkaf005","article-title":"Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds","volume":"80","author":"Morrissey","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia\u2013forming moulds","volume":"14","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0732-8893(02)00544-8","article-title":"In vitro susceptibility testing of filamentous fungi: Comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs","volume":"45","author":"Pfaller","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.funbio.2015.10.006","article-title":"Accuracy of the high-throughput amplicon sequencing to identify species within the genus Aspergillus","volume":"119","author":"Lee","year":"2015","journal-title":"Fungal Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/ijmm.IJMM_17_190","article-title":"Standardization of a two-step real-time polymerase chain reaction based method for species-specific detection of medically important Aspergillus species","volume":"35","author":"Das","year":"2017","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e0063424","DOI":"10.1128\/spectrum.00634-24","article-title":"Development of a TaqMan probe-based multiplex real-time PCR for the simultaneous detection of four clinically important filamentous fungi","volume":"12","author":"Wei","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/AAC.05902-11","article-title":"Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients","volume":"56","author":"Spiess","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e00604-19","DOI":"10.1128\/JCM.00604-19","article-title":"A novel broad allele-specific TaqMan real-time PCR method to detect triazole-resistant strains of Aspergillus fumigatus, even with a very low percentage of triazole-resistant cells mixed with triazole-susceptible cells","volume":"57","author":"Wang","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/cid\/ciad141","article-title":"Clinical impact of polymerase chain reaction-based Aspergillus and azole resistance detection in invasive aspergillosis: A prospective multicenter study","volume":"77","author":"Huygens","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14737159.2023.2267977","article-title":"An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections","volume":"23","author":"Jenks","year":"2023","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_137","first-page":"e00536","article-title":"Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing","volume":"6","author":"Abdolrasouli","year":"2015","journal-title":"mBio"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"myaf012","DOI":"10.1093\/mmy\/myaf012","article-title":"Genomic investigation of an antifungal-resistant Aspergillus fumigatus outbreak in a French hospital","volume":"63","author":"Joste","year":"2025","journal-title":"Med. Mycol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3314\/mmj.24-00031","article-title":"Large-scale expansion of the MALDI-TOF MS library for comprehensive identification of yeasts and filamentous fungi in clinical and sanitary contexts","volume":"66","author":"Ban","year":"2025","journal-title":"Med. Mycol. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e0154824","DOI":"10.1128\/jcm.01548-24","article-title":"Evaluation of two MALDI-TOF MS systems and extraction methods for identification of filamentous fungi recovered from clinical specimens","volume":"63","author":"Ransom","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cmi.2021.06.005","article-title":"Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry","volume":"28","author":"Zvezdanova","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"22998","DOI":"10.1038\/s41598-021-02350-8","article-title":"Droplet-based microfluidics platform for antifungal analysis against filamentous fungi","volume":"11","author":"Iftikhar","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","article-title":"Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official american thoracic society clinical practice guideline","volume":"200","author":"Hage","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa1943","article-title":"Assessment of the role of 1,3-\u03b2-d-glucan testing for the diagnosis of invasive fungal infections in adults","volume":"72","author":"Lamoth","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"579990","DOI":"10.2147\/IDR.S579990","article-title":"Current evidence on voriconazole exposure and individualized therapy for aspergillosis","volume":"19","author":"Wu","year":"2026","journal-title":"Infect. Drug Resist."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"107619","DOI":"10.1016\/j.ijantimicag.2025.107619","article-title":"Therapeutic drug monitoring of isavuconazole: Trends and update","volume":"66","author":"Tan","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FTD.0000000000000931","article-title":"Therapeutic drug monitoring of the echinocandin antifungal agents: Is there a role in clinical practice? A position statement of the anti-infective drugs committee of the international association of therapeutic drug monitoring and clinical toxicology","volume":"44","author":"Kim","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: A randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: An initiative of the European confederation of medical mycology in cooperation with the international society for human and animal mycology and the american society for microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/trf.13099","article-title":"Role of granulocyte transfusions in invasive fusariosis: Systematic review and single-center experience","volume":"55","author":"Kadri","year":"2015","journal-title":"Transfusion"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pulmoe.2018.04.005","article-title":"Pulmonary aspergillomas management: A 26-years case series of surgical therapy","volume":"24","author":"Vieira","year":"2018","journal-title":"Pulmonology"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/infdis\/163.4.908","article-title":"Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease","volume":"163","author":"Camargo","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1128\/AAC.01111-13","article-title":"Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method","volume":"57","author":"Howard","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Vuong, N.N., Mcclung, D.R., Aitken, S.L., and Rausch, C.R. (2026). New antifungals for the treatment of invasive mould disease. Clin. Microbiol. Infect.","DOI":"10.1016\/j.cmi.2026.03.035"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/fmb-2020-0217","article-title":"Rezafungin: A novel antifungal for the treatment of invasive candidiasis","volume":"16","author":"Ham","year":"2021","journal-title":"Future Microbiol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Vahedi-Shahandashti, R., Houbraken, J., Birch, M., and Lass-Fl\u00f6rl, C. (2023). Novel antifungals and Aspergillus section Terrei with potpourri susceptibility profiles to conventional antifungals. J. Fungi, 9.","DOI":"10.20944\/preprints202305.1236.v1"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Rabaan, A.A., Alfaraj, A.H., Alshengeti, A., Alawfi, A., Alwarthan, S., Alhajri, M., Al-Najjar, A.H., Al Fares, M.A., Najim, M.A., and Almuthree, S.A. (2023). Antibodies to combat fungal infections: Development strategies and progress. Microorganisms, 11.","DOI":"10.3390\/microorganisms11030671"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Khalifa, H.O., Oreiby, A., Abdelhamid, M.a.A., Ki, M.R., and Pack, S.P. (2024). Biomimetic antifungal materials: Countering the challenge of multidrug-resistant fungi. Biomimetics, 9.","DOI":"10.3390\/biomimetics9070425"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The deferasirox-ambisome therapy for mucormycosis (DEFEAT Mucor) study: A randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/21505594.2016.1226721","article-title":"Antifungal stewardship considerations for adults and pediatrics","volume":"8","author":"Hamdy","year":"2017","journal-title":"Virulence"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/8\/565\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:17:31Z","timestamp":1785759451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/8\/565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":163,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jof12080565"],"URL":"https:\/\/doi.org\/10.3390\/jof12080565","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}